Tag: Vascular Therapies
Vascular Therapies initiates enrolment in ACCESS 2 clinical trial
Vascular Therapies has announced that the first patient in the ACCESS 2 clinical trial was enrolled by Nikhil Kansal at Harbor-UCLA Medical Center in Torrance, USA.
The...
Sirogen™: A potential solution for improving arteriovenous fistula maturation
This advertorial is sponsored by Vascular Therapies
Arteriovenous fistula (AVF) maturation is a pivotal event in patients requiring haemodialysis. Maximising the number of fistulas that...
Vascular Therapies closes US$25 million in private financing to advance proprietary...
Vascular Therapies today announced the closing of US$25 million in private financing. The financing in question comprised of both existing and new investors, including...